22-37771749-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001039141.3(TRIOBP):c.6936+13G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,613,738 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00041 ( 2 hom., cov: 32)
Exomes 𝑓: 0.000068 ( 1 hom. )
Consequence
TRIOBP
NM_001039141.3 intron
NM_001039141.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.588
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 22-37771749-G-T is Benign according to our data. Variant chr22-37771749-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 165615.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000414 (63/152280) while in subpopulation AMR AF= 0.00405 (62/15302). AF 95% confidence interval is 0.00324. There are 2 homozygotes in gnomad4. There are 39 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIOBP | ENST00000644935.1 | c.6936+13G>T | intron_variant | NM_001039141.3 | ENSP00000496394.1 | |||||
TRIOBP | ENST00000403663.6 | c.1797+13G>T | intron_variant | 1 | ENSP00000386026.2 | |||||
TRIOBP | ENST00000344404.10 | n.*6419+13G>T | intron_variant | 2 | ENSP00000340312.6 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152162Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
63
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000277 AC: 69AN: 249312Hom.: 1 AF XY: 0.000177 AC XY: 24AN XY: 135316
GnomAD3 exomes
AF:
AC:
69
AN:
249312
Hom.:
AF XY:
AC XY:
24
AN XY:
135316
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000684 AC: 100AN: 1461458Hom.: 1 Cov.: 31 AF XY: 0.0000413 AC XY: 30AN XY: 727034
GnomAD4 exome
AF:
AC:
100
AN:
1461458
Hom.:
Cov.:
31
AF XY:
AC XY:
30
AN XY:
727034
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000414 AC: 63AN: 152280Hom.: 2 Cov.: 32 AF XY: 0.000524 AC XY: 39AN XY: 74458
GnomAD4 genome
AF:
AC:
63
AN:
152280
Hom.:
Cov.:
32
AF XY:
AC XY:
39
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2017 | c.6936+13G>T in intron 22 of TRIOBP: This variant is not expected to have clinic al significance because it does not alter an amino acid residue and is not locat ed within the splice consensus sequence. It has been identified in 0.2% (69/3358 0) of Latino chromosomes, including 1 homozygote, by the Genome Aggregation Data base (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs727503529). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 03, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at